组蛋白
表观遗传学
乙酰化
癌症研究
生物
癌症
染色质
转移
染色质重塑
癌症表观遗传学
医学
组蛋白甲基转移酶
遗传学
基因
作者
Wenkang Fu,Long Gao,Chongfei Huang,Jia Yao,Yanyan Lin,Bing Bai,Ping Yue,Ying Liu,Wenbo Meng,Liang Qiao,Xun Li
出处
期刊:PubMed
日期:2019-07-01
卷期号:28 (151): 17-28
被引量:4
摘要
Hepatobiliary cancers have poor prognosis due to their high level of invasiveness, distant metastasis, and chemotherapy resistance. Hepatocellular carcinoma is the most common type of hepatobiliary cancers representing the fourth leading cause of cancer death worldwide. There is an urgent need to identify the molecular drivers of hepatobiliary cancers to improve the therapeutic outcomes and patient prognosis. Histone modification is an important biological process that is critical in the regulation of epigenetic maintenance and modifications which in turn exert critical impacts on gene expression and chromatin structure stability. Histones may undergo a series of enzyme-catalyzed post-translational modifications such as acetylation, methylation, phosphorylation, ubiquitination, SUMOylating, crotonylation, and 2-hydroxyisobutyrylation. Dysregulation of histone-modifying enzyme may cause multiple diseases including cancers. As such, histone-modifying enzymes constitute a group of potential therapeutic targets. The aim of this review is to summarize the current understanding of the role of histone modification enzymes in regulating epigenetic alterations, cancer development, and their potential as therapeutic targets for hepatobiliary cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI